Economic evaluation of linezolid versus teicoplanin for the treatment of infections caused by gram-positive microorganisms in Spain.

about

Cost-effectiveness and pricing of antibacterial drugs.Detection of new mutations conferring resistance to linezolid in glycopeptide-intermediate susceptibility Staphylococcus hominis subspecies hominis circulating in an intensive care unit.

P2860

Q35084162-72674C35-56D1-4364-B9A8-2E6CA73A617A Q43252069-62018EB5-4F8F-48D6-BCF5-440E2772FDB0

P2860

Economic evaluation of linezolid versus teicoplanin for the treatment of infections caused by gram-positive microorganisms in Spain.

Item

http://www.wikidata.org/entity/Q44115544

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Economic evaluation of linezol ...... itive microorganisms in Spain.

@en

Economic evaluation of linezol ...... itive microorganisms in Spain.

@nl

type

Item

label

Economic evaluation of linezol ...... itive microorganisms in Spain.

@en

Economic evaluation of linezol ...... itive microorganisms in Spain.

@nl

prefLabel

Economic evaluation of linezol ...... itive microorganisms in Spain.

@en

Economic evaluation of linezol ...... itive microorganisms in Spain.

@nl

P1476

Economic evaluation of linezol ...... itive microorganisms in Spain.

@en

P2093

Aguado JM

http://www.w3.org/2001/XMLSchema#string

Del Castillo A

http://www.w3.org/2001/XMLSchema#string

Gonzalez P

http://www.w3.org/2001/XMLSchema#string

Grau S

http://www.w3.org/2001/XMLSchema#string

Mateu-de Antonio J

http://www.w3.org/2001/XMLSchema#string

P2860

A review of linezolid: the first oxazolidinone antibiotic.

Linezolid: in infants and children with severe Gram-positive infections.

Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia.

[Epidemiologic study of infection by resistant gram-positive bacteria (G + R Study)].

Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin.

Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections.

Nosocomial bloodstream infections in United States hospitals: a three-year analysis.

Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.

Cost-effectiveness analysis of the treatment of ventilator-associated pneumonia with linezolid or vancomycin in Spain.

Pharmacoeconomic evaluation of linezolid versus teicoplanin in bacteremia by Gram-positive microorganisms.

P304

398-409

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1179/JOC.2007.19.4.398

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17855184

http://www.w3.org/2001/XMLSchema#string

P921

Gram-positive bacteria

Economic evaluation of linezolid versus teicoplanin for the treatment of infections caused by gram-positive microorganisms in Spain.

about

P2860

P2860

Economic evaluation of linezolid versus teicoplanin for the treatment of infections caused by gram-positive microorganisms in Spain.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921